This opportunity is no longer accepting applications.
grant RFA-DA-25-008

Chemical Probes and Drugs for Modulating HIV Transcription in the Context of Substance Use Disorders (R21 Clinical Trial Not Allowed)

This grant opportunity aims to support research focused on tackling HIV infection in individuals with substance use disorders (SUD). It seeks proposals for projects that will: (1) Identify targets and pathways to suppress HIV transcription in HIV reservoirs, such as the central nervous system, in people with SUD. (2) Apply new drug discovery methods to find compounds that could help suppress H…

HIV infection and substance use are comorbid conditions that bidirectionally and synergistically influence the deleterious outcomes in people who suffer from substance use disorders (SUD). The persistence and transcriptional reactivation of HIV lead to the development of neuropathological compl…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: December 20, 2023
Open for Submission: December 20, 2023
Submission Deadline: August 13, 2024
Application Window Closes: August 13, 2024

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.